Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) stock fell -0.73% on Friday to $12.16 against a previous-day closing price of $12.25. With 0.67 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.65 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $12.39 whereas the lowest price it dropped to was $12.03. The 52-week range on DCPH shows that it touched its highest point at $22.76 and its lowest point at $9.90 during that stretch. It currently has a 1-year price target of $24.44. Beta for the stock currently stands at 0.49.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DCPH was up-trending over the past week, with a rise of 5.65%, but this was up by 15.15% over a month. Three-month performance dropped to -18.44% while six-month performance fell -17.73%. The stock lost -20.16% in the past year, while it has lost -25.81% so far this year. A look at the trailing 12-month EPS for DCPH yields -2.35 with Next year EPS estimates of -2.36. For the next quarter, that number is -0.59. This implies an EPS growth rate of 0.68% for this year and -0.30% for next year. EPS is expected to grow by 21.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 4.54%.
Float and Shares Shorts:
At present, 67.64 million DCPH shares are outstanding with a float of 48.13 million shares on hand for trading. On Oct 30, 2023, short shares totaled 3.91 million, which was 4.88% higher than short shares on Sep 28, 2023. In addition to DCTH as the firm’s Delcath Systems, Inc., SCPH serves as its scPharmaceuticals Inc..
Through their ownership of 75.15% of DCPH’s outstanding shares, institutional investors have majority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DCPH since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With DCPH analysts setting a high price target of $34.00 and a low target of $9.00, the average target price over the next 12 months is $24.44. Based on these targets, DCPH could surge 179.61% to reach the target high and fall by -25.99% to reach the target low. Reaching the average price target will result in a growth of 100.99% from current levels.
Summary of Insider Activity:
Insiders traded DCPH stock several times over the past three months with 7 Buys and 6 Sells. In these transactions, 231,040 shares were bought while 32,005 shares were sold. The number of buy transactions has increased to 16 while that of sell transactions has risen to 23 over the past year. The total number of shares bought during that period was 4,418,165 while 93,435 shares were sold.